What's new

Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 7, Status: Authorised

May 15, 2025 - 13:46
 0
Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 7, Status: Authorised
Read More

Tags:

Previous Article

Kinase inhibitor biotech Enliven calls time on phase 1 HER2 solid tumor program

Next Article

Human medicines European public assessment report (EPAR): Riluzole Zentiva, rilu...

Related Posts

Agenda of the PRAC meeting 5-8 May 2025

May 6, 2025  0

PSUSA/00010072/202409

PSUSA/00010072/202409

May 12, 2025  0

EMEA-003603-PIP01-24

EMEA-003603-PIP01-24

May 13, 2025  0